Document is current
Any future updates will be listed below
-
Authors
Benzaquén, Ana https://orcid.org/0000-0003-4015-0831
Giménez, Estela
Iacoboni, Gloria
Guerreiro, Manuel https://orcid.org/0000-0001-5978-2578
Hernani, Rafael
Albert, Eliseo
Carpio, Cecilia https://orcid.org/0000-0001-9346-0134
Balaguer, Aitana
Pérez, Ariadna
S de la Asunción, Carlos
Sánchez-Salinas, Mario Andrés
Chorão, Pedro https://orcid.org/0000-0001-6741-971X
Piñana, José Luis https://orcid.org/0000-0001-8533-2562
Beas, Francisco
Montoro, Juan https://orcid.org/0000-0003-0024-8068
Hernández-Boluda, Juan Carlos https://orcid.org/0000-0002-4289-3113
Facal, Ana
Ferrer, Blanca
Villalba, Marta
Amat, Paula
Goméz, María Dolores
Campos, Diana
Terol, María José
Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Barba, Pere
Navarro, David https://orcid.org/0000-0003-3010-4110
Solano, Carlos https://orcid.org/0000-0003-3702-0817
-
Funding
Funding for this research was provided by:
Fundación Española de Hematología y Hemoterapia
Gilead Sciences
- License Information
-
More Information
Article History
Received: 24 April 2023
Revised: 31 August 2023
Accepted: 20 September 2023
First Online: 2 November 2023
Competing interests
: A Gilead grant (Beca FEHH-GILEAD para Formación en Investigación en Terapia Celular en un centro internacional Convocatoria 2019) was awarded to AB. RH was the principal investigator of the grant-associated study. The authors declare no competing interests.
